US breakthrough for Crawford
Date added:
15/02/2017
Fast-growing wound care company Crawford Healthcare has been given key clearance by US Food and Drug Administration (FDA) for a world-first wound dressing.The product developed by Knutsford, Cheshire-based Crawford in partnership with the University of Manchester, is the first FDA-cleared absorbent gelling dressing containing unique Oxysalt technology.It will initially be available for clinical use in the US – the world’s largest market for advanced wound care, representing almost half of global spend.The revolutionary...
Back to all news